ALB and neoplasm: Importantly, albumin can be inherently formulated in the hydrophobic anticancer drugs in its hydrophobic interiors, thereby improving pharmacokinetic (PK) profiles with an enhanced circulatory half-life of drugs for tumor-targeted delivery [18,19].